Activin E is a TGFβ ligand that signals specifically through activin receptor-like kinase 7.

adipocytes molecular mechanisms receptor tyrosine kinases transforming growth factors

Journal

The Biochemical journal
ISSN: 1470-8728
Titre abrégé: Biochem J
Pays: England
ID NLM: 2984726R

Informations de publication

Date de publication:
27 Mar 2024
Historique:
accepted: 26 03 2024
received: 26 09 2023
revised: 09 02 2024
medline: 27 3 2024
pubmed: 27 3 2024
entrez: 27 3 2024
Statut: aheadofprint

Résumé

Activins are one of the three distinct subclasses within the greater Transforming Growth Factor β (TGFβ) superfamily. First discovered for their critical roles in reproductive biology, activins have since been shown to alter cellular differentiation and proliferation. At present, members of the activin subclass include activin A (ActA), ActB, ActC, ActE, and the more distant members myostatin and GDF11. While the biological roles and signaling mechanisms of most activins class members have been well-studied, the signaling potential of ActE has remained largely unknown. Here, we characterized the signaling capacity of homodimeric ActE. Molecular modeling of the ligand:receptor complexes showed that ActC and ActE shared high similarity in both the type I and type II receptor binding epitopes. ActE signaled specifically through ALK7, utilized the canonical activin type II receptors, ActRIIA and ActRIIB, and was resistant to the extracellular antagonists follistatin and WFIKKN. In mature murine adipocytes, ActE invoked a SMAD2/3 response via ALK7, like ActC. Collectively, our results establish ActE as a specific signaling ligand which activates the type I receptor, ALK7.

Identifiants

pubmed: 38533769
pii: 234235
doi: 10.1042/BCJ20230404
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright 2024 The Author(s).

Auteurs

Kylie A Vestal (KA)

University of Cincinnati College of Medicine, Cincinnati, Ohio, United States.

Chandramohan Kattamuri (C)

University of Cincinnati, Cincinnati, Ohio, United States.

Muhasin Koyiloth (M)

University of Cincinnati College of Medicine, Cincinnati, Ohio, United States.

Luisina Ongaro (L)

McGill University, Montreal, Canada.

James A Howard (JA)

University of Cincinnati College of Medicine, Cincinnati, Ohio, United States.

Aimee Deaton (A)

Alnylam Pharmaceuticals Inc, Cambridge, Massachusetts, United States.

Simina Ticau (S)

Alnylam Pharmaceuticals Inc, Cambridge, Massachusetts, United States.

Aditi Dubey (A)

Alnylam Pharmaceuticals Inc, Cambridge, Massachusetts, United States.

Daniel J Bernard (DJ)

McGill University, Montreal, Canada.

Thomas B Thompson (TB)

University of Cincinnati College of Medicine, Cincinnati, Ohio, United States.

Classifications MeSH